Fibrillary Glomerulopathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2022-09-22
Clinical Trial Update: Comparative and Efficacy Study of ACTHar Gel Alone or in Combination With Tacrolimus in Fibrillary Glomerulopathy [Phase 4]
A Phase 4 trial evaluating ACTHar Gel alone or with tacrolimus for fibrillary glomerulopathy was withdrawn.